Scarletred

07/05/2026

⏰ Counting down to 7th Dermatology Drug Development Summit Europe!

🌟 is proud to be a long-trusted Main Sponsor and Expertise Partner at this year’s Europe!

🗓️ 19th - 21st May 2026
📍Amsterdam, Netherlands

🎙️ Speaker Alert!

Listen to Harald Schnidar, CEO & Founder of , as an at 7th DDDS Europe - presenting:

🔊 From Images to Evidence: How Mobile Imaging and ®AI Are Redefining Dermatology Drug Development

💡 Visit our booth for a hands-on experience of Scarletred®Vision!

By enabling standardized, objective skin imaging at scale, we are supporting pharma and biotech in making faster, data-driven decisions across all phases of clinical research.

Let’s connect and explore how supports clinical trials with standardized documentation and clinically validated, objective skin data 🧬

🌟 We are looking forward to inspiring conversations!

06/05/2026

🌸 Bridging Innovation Across Borders 🌸

SCARLETRED is honored to return to this year’s Cherry Blossom Event at Vienna Airport City as a 🌟

is an inspiring platform that brings together Austrian and Japanese business communities to exchange ideas and shape the future of international partnerships.

At , innovation thrives at the intersection of science, technology, and global cooperation. That’s why this event resonates strongly with our mission. 🤝

🎙️ Speaker Alert!

Our CEO & Founder, Harald Schnidar, will take the stage as a keynote speaker in the Opening Panel, reflecting on how we can address economic challenges in today’s dynamic business environment.

💡From high-level economic dialogue and startup pitches to cultural exchange and networking, the program reflects how collaboration should look like: multidimensional, inclusive, and impactful.

We look forward to meaningful conversations and strengthening the bridge between Austria 🇦🇹 and Japan 🇯🇵

📍 Vienna Airport City
📅 May 18th, 2026
⏰ 9.00 - 17.30

🔗 Find more information on our website: https://www.scarletred.com/news/scarletred-takes-the-stage-at-cherry-blossom-business-and-culture-event-2026-as-gold-sponsor?utm_source=facebook&utm_medium=organic_social&utm_campaign=cherryblossom2026

28/04/2026

🌸 April is not over yet - and so is Awareness Month 🔊

Over 5% of adults worldwide live with Rosacea. And yet, it’s widely misunderstood, often dismissed as simple redness.

Rosacea is more than redness. It is a complex, multi-dimensional skin-disease, involving:

🔎 erythema
🔎 broken blood vessels
🔎 pustules
🔎 inflammatory lesions
🔎 structural skin changes

🔬One of the biggest challenges in managing today:
Measurement is largely subjective - occasionally leading to inaccurate and prolonged treatment.

Scarletred®Vision is here to help:
💪 Powered by ARORA®AI, Scarletred®Vision goes beyond redness – profiling Rosacea in all its dimensions.

👇Swipe through to learn more about and how AI-driven Profiling is changing the way we understand and manage Rosacea.

🌟 Dermatology deserves objectivity, every skin deserves precision.

🔗 Read more in our publication "Beyond Redness: AI-driven Profiling of Rosacea Severity and Morphological Marker": https://www.scarletred.com/publications/beyond-redness-ai-driven-profiling-of-rosacea-severity-and-morphological-marker?utm_source=facebook&utm_medium=organic_social&utm_campaign=rosaceaawareness

22/04/2026

🔬 Building the future of clinical research in Austria 🔬

had the privilege of joining Medical University of Vienna (MedUni Wien) for the official presentation of its New Clinical Research Hub:

💡The Center for Translational Medicine (CTM) and the Eric Kandel Institute – Center for Precision Medicine (CPM).

Thank you for your warm welcome Markus Zeitlinger, Head of Department of Clinical Pharmacology of MedUni Vienna, and Agnes Bugajska-Schretter!

🤝 This invitation reflects a strong and growing collaboration. Over the past years, we have worked together on impactful research projects:

🌟 From medical device studies on the sensitivity and specificity of SARS-CoV-2 rapid antigen tests
🌟 to a first in human Phase Ib trial, validating safety of subcutaneous recombinant Human Superoxide Dismutase (rhSOD) by integrating Artificial Intelligence.

What’s emerging now at the Medical University of Vienna goes far beyond infrastructure:

📍 A new campus designed to bring research, clinical practice, and education closer together - accelerating the translation from lab to patient and fostering data-driven medicine.

🔬 With dedicated spaces such as the CTM and the CPM and a strong focus on interdisciplinary innovation, this development marks a significant step for Austria’s clinical research landscape.

We are proud to contribute to this momentum and look forward to expanding collaboration opportunities 🤝

🔗 Read more about our collaborative research on our website.

SCARLETRED was invited by MedUni Wien to the presentation of its new clinical research hub: the Center for Translational Medicine (CTM) and the Eric Kandel Institute - Center for Precision Medicine (CPM).

15/04/2026

🚀 Wrapping up an amazing ! 🇺🇸

We had remarkable days at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado! 🌟

🎥 Take a moment to relive our highlights in our recap video - from engaging booth conversations to live demos of Scarletred®Vision and our agentic AI ® in action.

The SCARLETRED team is beyond grateful for the inspiring exchanges and the incredible interest in advancing -powered clinical skin imaging.

💫 A big thank you to everyone who stopped by ,
💫 to those exploring new approaches to precise skin endpoint documentation,
💫 and to all who made this event truly memorable!

📍 Let’s meet again at in San Francisco, California!

🚀 We are looking forward to innovating together! 🚀

14/04/2026

🚀 A strong step towards global safety 🚀

We were delighted to welcome the International Vaccine Institute (IVI) to our SCARLETRED Holding GmbH HQ in Vienna.

👉 IVI's visit marks an exciting step driven by a shared vision: advancing safe, effective, and globally accessible vaccines through digital innovation. 🌟

Represented by Dr. Kerstin Westritschnig and Colin McCann, IVI visited to explore collaboration opportunities in advancing vaccine safety and efficacy worldwide.

🌍 With a mission rooted in improving access to safe and affordable vaccines, IVI intensifies its global impact across continents.

💡 A key highlight of our exchange: the increasing importance of standardized, AI-powered detection, monitoring and quantification of Injection Site Reactions ( ).

🔬 With growing focus from FDA (Food and Drug Administration) and EMA (European Medicines Agency), objective approaches to ISR assessment are becoming essential in modern clinical trials.

’s AI-powered solution Scarletred®Vision enables
📈 scalable, patient-driven ISR monitoring,
🔎 delivering consistent, high-quality data across sites,
🔬 supporting more efficient and reliable vaccine development.

🔗 Read more about AI-powered ISR monitoring below.

The International Vaccine Institute (IVI) visited the SCARLETRED Headquarters in Vienna. The joint meeting highlighted the importance of companionship and collaboration for safety, efficacy and affordability of vaccines.

09/04/2026

🌸 Lisbon celebrated innovation this spring at BIO-Europe Spring 2026 and was thrilled to be part of the buzz!

It was an incredible opportunity to connect with partners, innovators, and thought leaders across the life sciences ecosystem 🌍

💪 From dynamic discussions on clinical skin imaging to the growing momentum for smartphone-based imaging, standardized documentation, and evidence-based clinical data - it’s clear the industry is moving toward faster, smarter and more reliable ways to run clinical trials. 📈

🤝 Inspiring conversations around out-licensing highlighted how helps companies generate robust clinical data, helping companies demonstrate asset value and navigate partnership opportunities more confidently, alongside clinical programs.

🌟A huge thank you to everyone we connected with - it was a pleasure exchanging ideas on how supports clinical trials with standardized documentation and clinically validated objective skin data.

📩 If we missed you in Lisbon, let’s keep the energy going - reach out anytime!

08/04/2026

🚀 Thank you – it was truly inspiring! 🇺🇸

SCARLETRED Inc. was honoured to be an exhibitor at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado! 🇺🇸

🌐 As one of the most influential global gatherings in dermatology, brings together clinicians, researchers, and industry leaders from around the world.

Our team is beyond thankful for three inspiring days of
🌟 connecting with so many peers at our ,
🌟 discussing new trends in digital dermatology and data-driven innovation,
🌟 showcasing Scarletred®Vision and our agentic AI ARORA® live,
🌟 having so many of you try our Fitzpatrick Analysis hands-on!

We are happy to connect beyond and continue to improve precise skin endpoint documentation in your clinical trial and research!

💪Strengthened in our mission, we are ready for in , California – from March 19–23, 2027! 🇺🇸

📍See you there – stronger than ever!

29/03/2026

🎉 Last chance to enter our Giveaway! 🎉

📍 Come to our at and get the chance to win a trip to Europe! ✈️

🌟 Try Scarletred®Vision live
🔬 Identify your Fitzpatrick Score
📲 Share your impressions on Social Media
🎁 Enter the winning pot!

This is your chance to win:

🥇 1st Prize: A Flight to the Headquarters in Vienna, Austria.
🥈 2nd Prize: An Apple iPhone (latest available model or equivalent).
🥉 3rd Prize: A Digital Dermatology Innovation Package.

🚀 We are looking forward to seeing you at our booth! 🚀



*Disclaimer:
This Giveaway is not sponsored, endorsed, administered by, or associated with LinkedIn, Instagram, Facebook, or the 2026 AAD Annual Meeting.

29/03/2026

🚀 Let's make Day 3 at iconic! 🇺🇸

The team has had two inspiring days at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver!

Haven't been to our Booth yet? It's more than time to stop by:

💫 Try Scarletred®Vision live
🔬 Identify your Score.
🎁 Enter the winning pot for our exclusive “Discover & Win” Giveaway.
💡 Discuss how we can support precise skin endpoint documentation in your upcoming clinical trials and research.

🚀 Let's connect - we are looking forward to welcoming you at our Booth! 🚀

29/03/2026

🚀 Let's make Day 3 at iconic! 🇺🇸

The team has already had two inspiring Days at the 2026 American Academy of Dermatology (AAD) Annual Meeting in !

📍 Haven't been to our Booth yet? Stop by at for something very special:

💫 Try Scarletred®Vision live!
🔬 Identify your Score.
🎁 Enter the winning pot for our exclusive “Discover & Win” Giveaway.
🎙️ Discuss how we can support precise skin endpoint documentation in your upcoming clinical trials and research.

🚀 Let's innovate together - we are looking forward to meeting you today! 🚀